Prognostic influence of clinicopathologic features, DNA-ploidy, CD44H and p53 expression in a large series of resected hepatocellular carcinoma in France

International Journal of Cancer

Volumn 74, Issue 6, 1997, Pages 614-619

  Terris, Benoît ^a   Laurent Puig, Pierre ^b   Belghiti, Jacques ^a   Degott, Claude ^a   Hénin, Dominique ^a   Fléjou, Jean François ^a  

^a BEAUJON HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ANIMAL TISSUE; ARTICLE; FEMALE; FLOW CYTOMETRY; FRANCE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; CARCINOMA, HEPATOCELLULAR; DNA, NEOPLASM; FEMALE; FRANCE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; PLOIDIES; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031470644     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971219)74:6<614::AID-IJC10>3.0.CO;2-5     Document Type: Article

References (38)

1. ADACHI, E., MAEDA, T., MATSUMATA, T., SHIRABE, K., KINUKAWA, N., SUGIMACHI, K. and TSUNEYOSHI, M., Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology, 108, 768-775 (1995).
2. BELGHITI, J., PANIS, Y., FARGES, O., BENHAMOU, J.P. and FEKETE, F., Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann. Surg., 214, 114-117 (1991).
3. BOURDON, J.C., D'ERRICO, A., PATERLINI, P., GRIGIONI, W., MAY, E. and DEBUIRE, B., p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53-gene mutation. Gastroenterology, 108, 1176-1182 (1995).
4. CALVET, X., BRUIX, J., GINÉS, P., BRU, C., SOLÉ, M., VILANA, R. and RODÉS, J., Prognostic factors of hepatocellular carcinoma in the West: a multivanate analysis in 206 patients. Hepatology, 12, 753-760 (1990).
5. CHIU, J.H., KAO, H.L., WU, L.H., CHANG, H.M. and LUI, W.Y., Prediction of relapse or survival after resection in human hepatomas by DNA flow cytometry. J. clin. Invest., 89, 539-545 (1992).
6. COLLIER, J.D., CARPENTER, M., BURT, A.D. and BASSENDINE, M.F., Expression of mutant p53 protein in hepatocellular carcinoma. Gut, 35, 98-100 (1994).
7. COTTIER, M., JOUFFRE, C., MAUBON, I., SABIDO, O., BARTHELEMY, C., CUILLERON, M., VEYRET, C., LAURENT, J.L. and AUDIGIER, J.C., Prospective flow-cytometric DNA analysis of hepatocellular carcinoma specimens collected by ultrasound-guided fine-needle aspiration. Cancer, 74, 599-605 (1994).
8. Cox, D.R., Regression models and life tables. J. roy. statist. Soc., 34, 197-220 (1972).
9. DELATTRE, O., LAW, D.J., REMVIKOS, Y., SASTRE, X., FEINBERG, A.P., OLSCHWANG, S., MELOT, T., SALMON, R.J., VALIDIRE, P. and THOMAS, G., Multiple genetic alterations in distal and proximal colorectal cancer. Lancet, II, 353-355 (1989).
10. D'ERRICO, A., GRIGIONI, W.F., FIORENTINO, M., BACCARINI, P., GRAZI, G.L. and MANCINI, A.M., Over-expression of p53 protein and Ki67 proliferative index in hepatocellular carcinoma: an immunohistochemical study on 109 Italian patients. Pathol. Int., 44, 682-687 (1994).
11. EDMONDSON, H.A. and STEINER, P.E., Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer, 7, 462-503 (1954).
12. FINALY, C.A., HINDS, P.W., TAN, T.H., ELIYAHU, D., OREN, M. and LEVINE, A.J., Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. cell. Biol., 8, 531-539 (1988).
13. FRANCO, D., CAPUSSOTTI, L., SMADJA, C., BOUZARI, H., MEAKINS, J., KEMENY, F., GRANGE, D. and DELLEPIANE, M., Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology, 98, 733-738 (1990).
14. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumour-suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
15. HSU, H.C., SHEU, J.C., LIN, Y.H., CHEN, D.S., LEE, C.S., HWANG, L.Y. and BEASLEY, R.P.C., Prognostic histologic features of resected small hepatocellular carcinoma (HCC) in Taiwan: a comparison with resected large HCC. Cancer, 56, 672-680 (1985).
16. HSU, H.C., TSENG, H.J., LAI, P.L., LEE, P.H. and PENG, S.Y., Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness. Cancer Res., 53, 4691-4694 (1993).
17. JALKANEN, S., JOGNSUU, H., SÖDERSTRÖM, K.O. and KLEMI, P., Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J. clin. Invest., 87, 1835-1840 (1991).
18. KAPLAN, E.L. and MEIER, P., Non-parametric estimation from incomplete observation. J. Amer. statist. Ass., 53, 457-481 (1958).
19. KAUFMANN, M., HEIDER, K.H., SINN, H.P., VON MINCKWITZ, G., PONTA, H. and HERRLICH, P., CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet, 345, 615-619 (1995).
20. KNODELL, R.G., ISHAK, K.G., BLACK, W.C., CHEN, T.S., CRAIG, R., KAPLOWITZ, N. and KIERNAN, T.W., Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology, 1, 431-435 (1981).
21. LAI, E.C.S., FAN, S.T., LO, C.M., CHU, K.M., C.L.LIU, C.L. and WONG, J., Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann. Surg., 221, 291-298 (1995).
22. LAI, E.C.S., NG, I.O.L., NG, M.M.T., LOK, A.S.F., TAM, P.C., FAN, S.T., CHOI, T.K. and WONG, J., Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathologic features. Hepatology, 11, 815-818 (1990).
23. LAURENT-PUIG, P., FLÉJOU, J.F., FABRE, M., BEDOSSA, P., BELGHITI, J., GAYRAL, F. and FRANCO, D., Over-expression of p53: a rare event in a large series of white patients with hepatocellular. Hepatology, 16, 1171-1175 (1992).
24. MATHEW, J., HINES, J.E., OBAFUNWA, J.O., BURR, A.W., TOOLE, K. and BURT, A.D., CD44 is expressed in hepatocellular carcinomas showing vascular invasion. J. Pathol., 179, 74-79 (1996).
25. MCENTEE, G.P., BATTS, K.A., KATZMAN, J.A., ILSTRUP, D.M. and NAGORNEY, D.M., Relationship of nuclear DNA content to clinical and pathologic findings in patients with primary hepatic malignancy. Surgery, 111, 376-379 (1992).
26. MERZAK, A., KOOCHECKPOUR, S. and PILKINGTON, G.J., CD44 mediates human glioma-cell adhesion and invasion in vitro. Cancer Res., 54, 3988-3992 (1994).
27. MULDER, J.W.R., KRUYT, P.M., SEWNATH, M., OOSTING, J., SELDENRIJK, C.A., WEIDEMA, W.F., OFFERHAUS, G.J. and PALS, S.T., Colorectal-cancer prognosis and expression of exon-v6 containing CD44 proteins. Lancet, 344, 1470-1472 (1994).
28. NAGASUE, N., UCHIDA, M., MAKINO, Y., TAKEMOTO, Y., YAMANOI, A., HAYASHI, T., CHANG, Y.C., KOHNO, H., NAKAMURA, T. and YUKAYA, H., Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology, 105, 488-494 (1993).
29. NAGASUE, N., YAMANOI, A., TAKEMOTO, Y., KIMOTO, T., UCHIDA, M., CHANG, Y.C., TANIURA, H., KOHNO, H. and NAKAMURA, T., Comparison between diploid and aneuploid hepatocellular carcinomas: a flow-cytometric study. Brit. J. Surg., 79, 667-670 (1992).
30. NG, I.O.L., LAI, E.C.S., CHAN, A.S.Y. and SO, M.K.P., Over-expression of p53 in hepatocellular carcinomas: a clinicopathological and prognostic correlation. J. Gastroenterol. Hepatol., 10, 250-255 (1995).
31. NG, I.O.L., LAI, E.C.S., HO, J.C.W., CHEUNG, L.K.N., NG, M.M.T. and SO, M.K.P., Flow-cytometric analysis of DNA ploidy in hepatocellular carcinoma. Amer. J. clin. Pathol., 102, 80-86 (1994).
32. OKADA, S., SHIMADA, K., YAMAMOTO, J., TAKAYAMA, T., KOSUGUE, T., YAMASAKI, S., SAKAMOTO, M. and HIROHASHI, S., Predictive factors for post-operative recurrence of hepatocellular carcinoma. Gastroenterology, 106, 1618-1624 (1994).
33. PATERLINI, P., FLÉJOU, J.F., DE MITRI, M.S., PISI, E., FRANCO, D. and BRÉCHOT, C., Structure and expression of the cyclin-A gene in human primary liver cancer. Correlation with flow-cytometric parameters. J. Hepatol., 23, 47-52 (1995).
34. PITRE, J., HOUSSIN, D. and KRACHT, M., Résection des carcinomes hépatocellulaires. Analyse des facteurs pronostiques d'une série multicentrique de 153 malades. Gastroenterol. clin. Biol., 17, 200-206 (1993).
35. PUGH, R.N.H., MURRAY-LYON, I.M., DAWSON, J.L., PIETRONI, M.E. and WILLIAMS, R., Transection of the esophagus for bleeding esophageal varices. Brit. J. Surg., 60, 646-649 (1973).
36. STUART, K.E., ANAND, A.J. and JENKINS, R.L., Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome and survival. Cancer, 77, 2217-2222 (1996).
37. SY, M.S., GUO, Y.J. and STAMENKOVIC, I., Distinct effects of 2 CD44 isoforms on tumor growth in vivo. J. exp. Med., 174, 859-866 (1991).
38. VAUTHEY, J.N., KLIMSTRA, D., FRANCESCHI, D., TAO, Y., FORTNER, J., BLUMGART, L. and BRENNAN, M., Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Amer. J. Surg., 169, 28-35 (1995).